Editorial Comment to Management and treatment options when facing malignant ureteral obstruction

Affiliations

Comment

Takashi Kawahara. Int J Urol. 2020 Jul.

. 2020 Jul;27(7):598.

doi: 10.1111/iju.14254. Epub 2020 Apr 28.

¹ Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.

No abstract available

Comment on

Management and treatment options when facing malignant ureteral obstruction.
Tabib C, Nethala D, Kozel Z, Okeke Z. Tabib C, et al. Int J Urol. 2020 Jul;27(7):591-598. doi: 10.1111/iju.14235. Epub 2020 Apr 6. Int J Urol. 2020. PMID: 32253785 Review.

1. Tabib C, Nethala D, Kozel Z, Okeke Z. Management and treatment options when facing malignant ureteral obstruction. Int. J. Urol. 2020; 27: 591-8.
1. Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J. Urol. 1967; 97: 840-4.
1. Asakawa J, Iguchi T, Tamada S et al. Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction. Int. J. Urol. 2018; 25: 258-62.
1. Ohtaka M, Kawahara T, Takamoto D et al. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure. BMC Urol. 2018; 18: 35.
1. Kawahara T, Takamoto D, Miyoshi Y, Yao M, Uemura H. Inserting a metallic ureteral stent using an antegrade approach freed a patient from nephrostomy created due to hydronephrosis caused by bladder cancer. Case Rep. Oncol. 2019; 12: 560-3.